Pfizer Keeps Hands On Consumer Product Wheel In Opting Against Split
This article was originally published in The Pink Sheet
Executive Summary
Pfizer didn't cite its consumer health business in announcing it will retain current structure, but best-selling Lipitor's cholesterol treatment indication is the most coveted indication yet to be available OTC.